XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.3

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

The following table summarizes stock option activity during the nine months ended September 30, 2024:

						Shares						Weighted- Average  Exercise Price						Weighted- Average Remaining Contractual Term						Aggregate Intrinsic Value
						(in thousands)												(in years)						(in thousands)
Outstanding at December 31, 2023						2,710						8.14						5.1						$	26,383
Granted						—						—
Exercised						(125)						2.48
Cancelled/forfeited						(33)						11.92
Outstanding at September 30, 2024						2,552						8.38						4.2						$	5,466
Vested and exercisable at September 30, 2024						2,100						6.63						3.2						$	5,466

Schedule of RSU, PSU, MPSUs Activity

The following table summarizes RSU activity during the nine months ended September 30, 2024:

						Number of Shares						Weighted-Average  Grant Date Fair Value Per Share
						(in thousands)
Unvested RSUs as of December 31, 2023						11,244						$	17.46
Granted						9,813						11.83
Vested						(6,180)						16.95
Cancelled/forfeited						(1,116)						17.51
Unvested RSUs as of September 30, 2024						13,761						$	13.73

						Number of Shares						Weighted-Average Grant Date Fair Value Per Share
						(in thousands)
Nonvested PSUs as of December 31, 2023						732						$	16.49
Granted						909						12.60
Vested						(239)						16.41
Cancelled/forfeited						(271)						16.43
Nonvested PSUs as of September 30, 2024						1,131						$	13.40

						Number of Shares						Weighted-Average Grant Date Fair Value Per Share
						(in thousands)
Nonvested MPSUs as of December 31, 2023						1,471						$	6.46
Granted						—						—
Vested						—						—
Cancelled/forfeited						(158)						6.56
Nonvested MPSUs as of September 30, 2024						1,313						$	6.45

Schedule of Stock-Based Compensation Expense

The following table summarizes the components of total stock-based compensation expense included in the accompanying condensed consolidated statements of operations:

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
						(in thousands)
Cost of revenue						$	1,911					$	2,860					$	6,734					$	8,378
Research and development						7,378						12,122						25,684						35,808
Sales and marketing						7,113						9,061						22,014						25,643
General and administrative						8,614						11,670						28,553						31,027
Total stock-based compensation expense						$	25,016					$	35,713					$	82,985					$	100,856

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration